SmallCap
CompaniesStatistics

파미셀(주)

Listed
Venture Certified
Data Quality: 9/10

Basic Information


Listed

Stock Code: 005690

Company Name파미셀(주)
Business Reg. No.3148100664
CEO김현수
Address서울특별시 강남구 언주로 874 (신사동, 쌍봉빌딩 7층)
Industry그 외 기타 분류 안된 화학제품 제조업
Industry Code211
Main Products줄기세포치료제
Established1968-08-20
Phone02-3496-0114
Websitewww.pharmicell.com
Regular EmployeesContact
Corp. Reg. No.1601110005177

Investment Metrics


Market Cap
-
Op. Margin
7.18%
ROE
7.25%
Debt Ratio
14.84%

Certification Status


Venture Certified

Cert. History
신기술기업(고도기술수반산업)2004-10-21 ~ 2006-10-20041635032100790-
연구개발유형2007-10-21 ~ 2008-10-2020060100269-
연구개발유형2008-10-21 ~ 2010-10-2020080106373-
연구개발유형2010-10-21 ~ 2012-10-2020100107415-
연구개발유형2012-11-26 ~ 2014-11-25201201091562012-11-26
연구개발유형2014-11-26 ~ 2016-11-25201401131422012-11-26
연구개발유형2016-11-26 ~ 2018-11-25201601131482012-11-26
연구개발유형2018-11-26 ~ 2020-11-25201801136192012-11-26
연구개발유형2020-11-26 ~ 2022-11-25202001165832012-11-26
연구개발유형2022-11-26 ~ 2025-11-25202212220200032012-11-26
연구개발유형2025-11-26 ~ 2028-11-25202512160200102012-11-26

Financial Statements


3-Year Financial Data

Revenue CAGR +3.8%

Item202420232022
Revenue

648.5B

562.3B

601.8B

Operating Profit

46.6B

13.0B

88.7B

Net Profit

62.6B

47.3B

59.7B

Total Assets

992.6B

925.2B

1096.5B

Total Liabilities

128.3B

121.2B

329.8B

Total Equity

864.4B

804.0B

766.6B

Comparison Metrics


vs. 3-Year Avg.
Based on 2024
Revenue
649B

11.4%

vs. 3-Year Avg.: 582B
Operating Profit
47B

8.4%

vs. 3-Year Avg.: 51B
Op. Margin
7.2%

15.8%

vs. 3-Year Avg.: 8.5%
Debt Ratio
14.8%

48.9%

vs. 3-Year Avg.: 29.0%
ROE
7.2%

6.0%

vs. 3-Year Avg.: 6.8%

Officers / Major Shareholders


Only CEO info available (unlisted company)
NamePositionRole
김현수대표이사대표

Employment Status


Regular EmployeesContact
CEO김현수

Patent Status

Updated: 2026-02-25

25 Patents
7 Registered
6 in 3 Years
A61 의학/수의학/위생 (34)
C12 생화학/미생물학 (21)
C07 유기화학 (9)
F25 냉동/냉각 (5)
A23 식품/식료품 (2)
Patent TitleApplicantApplication No.Filing DateStatus
배양용기, 이를 포함하는 세포배양장치 및 세포배양방법파미셀 주식회사10202301312112023-09-27공개
배양용기, 이를 포함하는 세포배양장치 및 세포배양방법파미셀 주식회사10202301312012023-09-27공개
졸레드로네이트를 통해 성숙된 WT1 정보를 가진 인간 CD141+ 수지상세포파미셀 주식회사10202301067582023-08-16공개
뉴클레오시드 함유 세포 배양배지 및 이를 이용한 세포 배양 방법파미셀 주식회사10202300931842023-07-18공개
대용량 고순도의 2'-디옥시-2'-플루오로우리딘의 제조 방법파미셀 주식회사10202300491692023-04-14등록

Procurement Record

Updated: 2026-02-25

No Data Contact

No procurement record or data not yet available

Support Programs


No Data Contact

No matching support programs for this industry

Tax / Business Status

Updated: 2026-02-25

Business Status: active
Tax Type부가가치세 일반과세자

SME Status


Venture
Status

Cert. flags confirmed (details update after further collection)

Other Public Data


1 Additional Data Sources

{
  "address": "서울특별시 강남구",
  "ceo_name": "김현수",
  "certificate": [
    {
      "cert_number": "041635032100790",
      "changes": "",
      "disclosure_date": "2004-10-21",
      "first_cert_date": "",
      "no": "1",
      "type": "신기술기업(고도기술수반산업)",
      "valid_period": "2004-10-21 ~ 2006-10-20"
    },
    {
      "cert_number": "20060100269",
      "changes": "",
      "disclosure_date": "2006-10-18",
      "first_cert_date": "",
      "no": "2",
      "type": "연구개발유형",
      "valid_period": "2007-10-21 ~ 2008-10-20"
    },
    {
      "cert_number": "20080106373",
      "changes": "",
      "disclosure_date": "2008-09-26",
      "first_cert_date": "",
      "no": "3",
      "type": "연구개발유형",
      "valid_period": "2008-10-21 ~ 2010-10-20"
    },
    {
      "cert_number": "20100107415",
      "changes": "",
      "disclosure_date": "2010-11-02",
      "first_cert_date": "",
      "no": "4",
      "type": "연구개발유형",
      "valid_period": "2010-10-21 ~ 2012-10-20"
    },
    {
      "cert_number": "20120109156",
      "changes": "",
      "disclosure_date": "2012-11-26",
      "first_cert_date": "2012-11-26",
      "no": "5",
      "type": "연구개발유형",
      "valid_period": "2012-11-26 ~ 2014-11-25"
    },
    {
      "cert_number": "20140113142",
      "changes": "",
      "disclosure_date": "2014-12-15",
      "first_cert_date": "2012-11-26",
      "no": "6",
      "type": "연구개발유형",
      "valid_period": "2014-11-26 ~ 2016-11-25"
    },
    {
      "cert_number": "20160113148",
      "changes": "",
      "disclosure_date": "2016-11-23",
      "first_cert_date": "2012-11-26",
      "no": "7",
      "type": "연구개발유형",
      "valid_period": "2016-11-26 ~ 2018-11-25"
    },
    {
      "cert_number": "20180113619",
      "changes": "",
      "disclosure_date": "2018-11-30",
      "first_cert_date": "2012-11-26",
      "no": "8",
      "type": "연구개발유형",
      "valid_period": "2018-11-26 ~ 2020-11-25"
    },
    {
      "cert_number": "20200116583",
      "changes": "",
      "disclosure_date": "2020-12-24",
      "first_cert_date": "2012-11-26",
      "no": "9",
      "type": "연구개발유형",
      "valid_period": "2020-11-26 ~ 2022-11-25"
    },
    {
      "cert_number": "20221222020003",
      "changes": "",
      "disclosure_date": "2022-12-22",
      "first_cert_date": "2012-11-26",
      "no": "10",
      "type": "연구개발유형",
      "valid_period": "2022-11-26 ~ 2025-11-25"
    },
    {
      "cert_number": "20251216020010",
      "changes": "",
      "disclosure_date": "2025-12-16",
      "first_cert_date": "2012-11-26",
      "no": "11",
      "type": "연구개발유형",
      "valid_period": "2025-11-26 ~ 2028-11-25"
    }
  ],
  "company_name": "파미셀 주식회사",
  "corp_no": "160111-*******",
  "financials": {
    "2022": {
      "capital_stock": 30008482000,
      "cost_of_sales": 36362213000,
      "current_assets": 62363173000,
      "current_liabilities": 28546176000,
      "gross_profit": 23819594000,
      "net_income": 5968957000,
      "net_income_bs": 8261768000,
      "non_current_assets": 47284016000,
      "non_current_liabilities": 4436098000,
      "non_operating_expenses": 6238995000,
      "non_operating_income": 3334585000,
      "operating_profit": 8873367000,
      "revenue": 60181807000,
      "sga_expenses": 14946227000,
      "total_assets": 109647189000,
      "total_equity": 76664915000,
      "total_liabilities": 32982274000
    },
    "2023": {
      "capital_stock": 30008481000,
      "cost_of_sales": 40735416000,
      "current_assets": 43166152000,
      "current_liabilities": 7763157000,
      "gross_profit": 15491963000,
      "net_income": 4732058000,
      "net_income_bs": 3577984000,
      "non_current_assets": 49352601000,
      "non_current_liabilities": 4358650000,
      "non_operating_expenses": 2938699000,
      "non_operating_income": 6374760000,
      "operating_profit": 1295997000,
      "revenue": 56227379000,
      "sga_expenses": 14195966000,
      "total_assets": 92518753000,
      "total_equity": 80396946000,
      "total_liabilities": 12121807000
    },
    "2024": {
      "capital_stock": 30008482000,
      "cost_of_sales": 43521158000,
      "current_assets": 48035031000,
      "current_liabilities": 7645983000,
      "gross_profit": 21330146000,
      "net_income": 6263975000,
      "net_income_bs": 6331277000,
      "non_current_assets": 51229286000,
      "non_current_liabilities": 5179164000,
      "non_operating_expenses": 1109001000,
      "non_operating_income": 2717339000,
      "operating_profit": 4655637000,
      "revenue": 64851304000,
      "sga_expenses": 16674509000,
      "total_assets": 99264317000,
      "total_equity": 86439170000,
      "total_liabilities": 12825147000
    }
  },
  "industry": "그 외 기타 분류 안된 화학제품 제조업",
  "investment": [],
  "main_products": "줄기세포치료제",
  "phone": "02-3496-****",
  "years": [
    2024,
    2023,
    2022
  ]
}